UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 296

Sortiert nach

Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis

Respiratory medicine, 2010-07, Vol.104 (7), p.1035-1041

2010

Link zum Volltext

Verfügbarkeit prüfen

Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation

The Journal of heart and lung transplantation, 2010-10, Vol.29 (10), p.1159-1164

2010

Link zum Volltext

Verfügbarkeit prüfen

Parameters of donor–recipient size mismatch and survival after bilateral lung transplantation

The Journal of heart and lung transplantation, 2012-11, Vol.31 (11), p.1207-1213.e7

2012

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary hypertension due to lung disease and/or hypoxia

Clinics in chest medicine, 2013-12, Vol.34 (4), p.695

2013

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Placebo-controlled, Double-blinded, Crossover Trial of Pioglitazone for Severe Asthma

Journal of allergy and clinical immunology, 2017-12, Vol.140 (6), p.1716-1718

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparison of wait times and mortality for idiopathic pulmonary fibrosis patients listed for single or bilateral lung transplantation

The Journal of heart and lung transplantation, 2010-10, Vol.29 (10), p.1165-1171

2010

Link zum Volltext

Verfügbarkeit prüfen

Idiopathic interstitial pneumonia-associated pulmonary hypertension: A target for therapy?

Respiratory medicine, 2017-01, Vol.122, p.S10-S13

2017

Link zum Volltext

Verfügbarkeit prüfen

The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis

Respiratory medicine, 2006-10, Vol.100 (10), p.1734-1741

2006

Link zum Volltext

Verfügbarkeit prüfen

Native Lung Complications in Single-lung Transplant Recipients and the Role of Pneumonectomy

The Journal of heart and lung transplantation, 2009-08, Vol.28 (8), p.851-856

2009

Link zum Volltext

Verfügbarkeit prüfen

Genomic phenotype of non-cultured pulmonary fibroblasts in idiopathic pulmonary fibrosis

Genomics (San Diego, Calif.), 2010-09, Vol.96 (3), p.134-145

2010

Link zum Volltext

Verfügbarkeit prüfen

sGC stimulators: Evidence for riociguat beyond groups 1 and 4 pulmonary hypertension

Respiratory medicine, 2017-01, Vol.122, p.S28-S34

2017

Link zum Volltext

Verfügbarkeit prüfen

Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study

The Journal of heart and lung transplantation, 2021-08, Vol.40 (8), p.822-830

2021

Link zum Volltext

Verfügbarkeit prüfen

Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD

The Journal of heart and lung transplantation, 2024-04, Vol.43 (4), p.547-553

2024

Link zum Volltext

Verfügbarkeit prüfen

Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment

Respiratory medicine, 2019-07, Vol.153, p.44-51

2019

Link zum Volltext

Verfügbarkeit prüfen

Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis

The Journal of heart and lung transplantation, 2018-07, Vol.37 (7), p.925-932

2018

Link zum Volltext

Verfügbarkeit prüfen

Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD)

The Journal of heart and lung transplantation, 2021-06, Vol.40 (6), p.488-493

2021

Link zum Volltext

Verfügbarkeit prüfen

The association between white blood cell count and outcomes in patients with idiopathic pulmonary fibrosis

Respiratory medicine, 2020-08, Vol.170, p.106068-106068, Article 106068

2020

Link zum Volltext

Verfügbarkeit prüfen

Standardization of the 6-min walk test in clinical trials of idiopathic pulmonary fibrosis

Contemporary clinical trials, 2021-01, Vol.100, p.106227-106227, Article 106227

2021

Link zum Volltext

Verfügbarkeit prüfen

Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury

The Journal of heart and lung transplantation, 2021-11, Vol.40 (11), p.1454-1462

2021

Link zum Volltext

Verfügbarkeit prüfen

Organizing pneumonia is associated with molecular allograft injury and the development of antibody-mediated rejection

The Journal of heart and lung transplantation, 2024-04, Vol.43 (4), p.563-570

2024

Link zum Volltext

Verfügbarkeit prüfen

Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis

Respiratory medicine, 2015-07, Vol.109 (7), p.914-922

2015

Link zum Volltext

Verfügbarkeit prüfen

Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease

The Journal of heart and lung transplantation, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Categorization and impact of pulmonary hypertension in patients with advanced COPD

Respiratory medicine, 2010-12, Vol.104 (12), p.1877-1882

2010

Link zum Volltext

Verfügbarkeit prüfen

Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension

Respiratory medicine, 2013-05, Vol.107 (5), p.778-784

2013

Link zum Volltext

Verfügbarkeit prüfen

The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry

Respiratory medicine, 2022-05, Vol.196, p.106801-106801, Article 106801

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 296

Suche als RSS-Feed

Aktive Filter

ThemaAnimals

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(292)
Mit Volltextzugriff
(287)

Publikationsform

Artikel
(295)
Berichte
(1)

Sprache

Englisch
(296)
Japanisch
(43)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis

Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation

Parameters of donor–recipient size mismatch and survival after bilateral lung transplantation

Pulmonary hypertension due to lung disease and/or hypoxia

A Randomized, Placebo-controlled, Double-blinded, Crossover Trial of Pioglitazone for Severe Asthma

Comparison of wait times and mortality for idiopathic pulmonary fibrosis patients listed for single or bilateral lung transplantation

Idiopathic interstitial pneumonia-associated pulmonary hypertension: A target for therapy?

The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis

Native Lung Complications in Single-lung Transplant Recipients and the Role of Pneumonectomy

Genomic phenotype of non-cultured pulmonary fibroblasts in idiopathic pulmonary fibrosis

sGC stimulators: Evidence for riociguat beyond groups 1 and 4 pulmonary hypertension

Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study

Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD

Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment

Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis

Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD)

The association between white blood cell count and outcomes in patients with idiopathic pulmonary fibrosis

Standardization of the 6-min walk test in clinical trials of idiopathic pulmonary fibrosis

Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury

Organizing pneumonia is associated with molecular allograft injury and the development of antibody-mediated rejection

Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis

Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease

Categorization and impact of pulmonary hypertension in patients with advanced COPD

Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension

The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry

Aktive Filter

Suchergebnisse filtern